XML 16 R7.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 28, 2025
Sep. 29, 2024
Cash Flows from Operating Activities:    
Net income $ 670,753 $ 207,433
Adjustments to reconcile net income to net cash provided by operating activities:    
Asset impairments 11,402 23,195
Depreciation and amortization 382,623 270,691
Share-based compensation expense 16,748 22,663
Equity in earnings of affiliated companies, net (7,211) (6,218)
Cash dividends from affiliated companies 4,903 5,624
Net loss/(gain) on disposition of assets 3,770 (529)
Net (gain)/loss on divestiture of business (616,476) 27,292
Gain on remeasurement of investment in affiliated companies 0 (6,012)
Pension and postretirement plan expense 13,145 13,068
Pension and postretirement plan contributions (16,734) (14,680)
Net decrease in deferred tax liabilities (64,686) (17,109)
Change in assets and liabilities, net of effects from acquisitions, divestitures and foreign currency adjustments:    
Trade accounts receivable (145,089) (182,626)
Inventories (108,492) (6,703)
Payable to suppliers (46,069) 73,504
Prepaid expenses 31,059 (38,851)
Income taxes payable and other income tax items 192,098 23,274
Accrued expenses and other assets and liabilities (44,848) 43,622
Net cash provided by operating activities 276,896 437,638
Cash Flows from Investing Activities:    
Purchases of property, plant and equipment (253,411) (271,332)
Cost of acquisition, net of cash acquired [1] 16,528 (3,743)
Proceeds from the sale of business, net 1,814,899 81,212
Proceeds from the sale of assets, net 5,160 4,515
Proceeds from settlement of net investment hedge 0 9,068
Investments in affiliated companies and other net investing proceeds 1,129 2,221
Net cash provided/(used) by investing activities 1,584,305 (178,059)
Cash Flows from Financing Activities:    
Proceeds from issuance of debt 54,531 1,813,754
Principal repayment of debt (2,082,940) (133,644)
Net change in commercial paper 90,000 33,983
Net increase/(decrease) in book cash overdrafts 14,741 (3,078)
Payment of loan financing costs 0 (19,000)
Payment of contingent consideration 0 (948)
Dividends paid to noncontrolling interests (243) 0
Cash dividends (155,767) (152,397)
Payments for share repurchases (10,580) (9,172)
Net cash (used)/provided by financing activities (2,090,258) 1,529,498
Effects of Exchange Rate Changes on Cash 31,863 (10,381)
Net (Decrease)/Increase in Cash and Cash Equivalents (197,194) 1,778,696
Cash and cash equivalents at beginning of period 443,060 151,937
Cash and cash equivalents at end of period $ 245,866 $ 1,930,633
[1] The Company received a final net working capital settlement of $16,528 during 2025 related to the acquisition of Titan Holdings I B.V. (“Eviosys”).